THURSDAY, June 5, 2025 (HealthDay News) — More American teenagers now use the weight-loss drug Wegovy, as doctors and ...

Wegovy (semaglutide) is approved by the U.S. Food and Drug Administration (FDA) for weight loss and weight management in ...

A trial was conducted comparing weight loss medications Zepbound and Wegovy. Results from the trial found that participants who took Zepbound lost more weight than those who took Wegovy.

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk's Wegovy. The study, published in the New England Journal of ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 percent more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

The weight loss drug Wegovy treated a serious form of liver disease in about two-thirds of patients in a major clinical trial, according to the findings published Wednesday in the New England ...

Wegovy, the popular weight-loss drug from Novo Nordisk, will be available through several leading telehealth providers, beginning this week. The company’s announcement comes as many compounding ...

By Dani Blum I’ve reported on Ozempic since 2022. New research shows that semaglutide, the compound in the weight-loss drug Wegovy, could treat an increasingly common liver disease. The study ...

The companies will sell the drug at a reduced price of $499 a month. Consumers looking to start the popular weight loss drug Wegovy but lacking insurance coverage will soon have a new option.

Wegovy versus Ozempic for weight loss — it’s the age-old question. Okay, not that old. But it’s a common question amid the rising popularity of these weight loss drugs. Wegovy and Ozempic ...

Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...

The use of weight loss treatments like Ozempic and Wegovy has skyrocketed in the Western world. But as more people turn to these treatments, which mimic the appetite-suppressing hormone GLP-1 ...